Amer Zeidan 🇺🇸
MBBS, MHS, a Professor of Medicine at Yale, Chief of Hematologic Malignancies, and Director of Early Therapeutics Research at Yale Cancer Center.
8:20 AM - 8:40 AM
Day 3 | Hematology Track
An update on immune checkpoint inhibition in management of higher risk MDS
9:00 AM - 9:20 AM
Day 3 | Hematology Track
Telomerase inhibition & TGF pathway targeting in management of lower risk MDS
Contact Us